1 Year Absolute Returns
24.53% ↑
NAV (₹) on 11 Sep 2026
12.49
1 Day NAV Change
-0.32%
Risk Level
Very High Risk
Rating
-
PGIM India Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by PGIM India Asset Management Pvt. Ltd.. Launched on 19 Nov 2024, investors can start with a minimum ... Read more
AUM
₹ 125.15 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 63.07% |
| Hospitals & Medical Services | 27.54% |
| Treps/Reverse Repo | 4.32% |
| Chemicals - Others | 2.81% |
| Finance - Non Life Insurance | 0.89% |
| Lenses/Optical Care | 0.68% |
| IT Enabled Services | 0.48% |
| Net Receivables/(Payables) | 0.21% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 10.86% | ₹ 12.12 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 10.35% | ₹ 11.55 | Pharmaceuticals |
| Torrent Pharmaceuticals Ltd. | 9.38% | ₹ 10.47 | Pharmaceuticals |
| Aster DM Quality Care Ltd. | 6.21% | ₹ 6.94 | Hospitals & Medical Services |
| Max Healthcare Institute Ltd. | 5.86% | ₹ 6.54 | Hospitals & Medical Services |
| Ajanta Pharma Ltd. | 5.20% | ₹ 5.81 | Pharmaceuticals |
| Mankind Pharma Ltd. | 4.66% | ₹ 5.20 | Pharmaceuticals |
| Clearing Corporation of India Ltd. | 4.32% | ₹ 4.82 | Others |
| Dr. Lal Path Labs Ltd. | 4.05% | ₹ 4.52 | Hospitals & Medical Services |
| Krishna Inst of Medical Sciences Ltd. | 3.77% | ₹ 4.20 | Hospitals & Medical Services |
| Rubicon Research Ltd. | 3.68% | ₹ 4.11 | Pharmaceuticals |
| Abbott India Ltd. | 3.23% | ₹ 3.61 | Pharmaceuticals |
| Neuland Laboratories Ltd. | 3.03% | ₹ 3.38 | Pharmaceuticals |
| Navin Fluorine International Ltd. | 2.81% | ₹ 3.14 | Chemicals - Others |
| Sai Life Sciences Ltd | 2.56% | ₹ 2.86 | Pharmaceuticals |
| Cipla Ltd. | 2.39% | ₹ 2.67 | Pharmaceuticals |
| Pfizer Ltd. | 2.25% | ₹ 2.52 | Pharmaceuticals |
| Jupiter Life Line Hospitals Ltd. | 2.23% | ₹ 2.48 | Hospitals & Medical Services |
| Anthem Biosciences Ltd. | 1.99% | ₹ 2.22 | Pharmaceuticals |
| Global Health Ltd. | 1.83% | ₹ 2.05 | Hospitals & Medical Services |
| Zydus Lifesciences Ltd. | 1.35% | ₹ 1.50 | Pharmaceuticals |
| Fortis Healthcare Ltd. | 1.28% | ₹ 1.43 | Hospitals & Medical Services |
| Lupin Ltd. | 1.23% | ₹ 1.37 | Pharmaceuticals |
| Manipal Health Enterprises Ltd. | 0.96% | ₹ 1.08 | Hospitals & Medical Services |
| Orchid Pharma Ltd. | 0.91% | ₹ 1.01 | Pharmaceuticals |
| Dr Agarwal's Health Care Ltd. | 0.90% | ₹ 1 | Hospitals & Medical Services |
| ICICI Lombard General Insurance Co. Ltd. | 0.89% | ₹ 0.99 | Finance - Non Life Insurance |
| Lenskart Solutions Ltd. | 0.68% | ₹ 0.76 | Lenses/Optical Care |
| Sagility Ltd. | 0.48% | ₹ 0.53 | IT Enabled Services |
| Dr Agarwal's Eye Hospital Ltd. | 0.45% | ₹ 0.50 | Hospitals & Medical Services |
| Net Receivables / (Payables) | 0.21% | ₹ 0.23 | Others |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 23.66% | 24.53% | - | - |
| Category returns | 5.65% | 5.83% | 4.91% | 20.14% |
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.86 | 114.25% | 314.64% | 0.00% | ₹1,128 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.86 | 114.25% | 314.64% | 0.00% | ₹1,128 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.86 | 114.25% | 314.64% | 0.00% | ₹1,128 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34.42 | 111.39% | 297.88% | 0.00% | ₹1,128 | 2.53% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34.42 | 111.39% | 297.88% | 0.00% | ₹1,128 | 2.53% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34.42 | 111.39% | 297.88% | 0.00% | ₹1,128 | 2.53% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.68 | 31.47% | 152.50% | 0.00% | ₹11,478 | 0.90% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.68 | 31.47% | 152.50% | 0.00% | ₹11,478 | 0.90% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.68 | 31.47% | 152.50% | 0.00% | ₹11,478 | 0.90% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹30.55 | 30.19% | 144.38% | 0.00% | ₹11,478 | 1.79% |
Very High
|
What is the current NAV of PGIM India Healthcare Fund - Direct Plan Growth?
What is the fund size (AUM) of PGIM India Healthcare Fund - Direct Plan Growth?
What are the historical returns of PGIM India Healthcare Fund - Direct Plan Growth?
What is the risk level of PGIM India Healthcare Fund - Direct Plan Growth?
What is the minimum investment amount for PGIM India Healthcare Fund - Direct Plan Growth?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article